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Invariant natural killer T cells (iNKT) cells are T lymphocytes display-
ing innate effector functions, acquired through a distinct thymic
developmental program regulated by microRNAs (miRNAs). Deleting
miRNAs by Dicer ablation (Dicer KO) in thymocytes selectively impairs
iNKT cell survival and functional differentiation. To unravel this
miRNA-dependent program, we systemically identified transcripts
that were differentially expressed between WT and Dicer KO iNKT
cells at different differentiation stages and predicted to be
targeted by the iNKT cell-specific miRNAs. TGF-β receptor II (TGF-
βRII), critically implicated in iNKT cell differentiation, was found
up-regulated in iNKT Dicer KO cells together with enhanced
TGF-β signaling. miRNA members of the miR-17∼92 family clusters
were predicted to target Tgfbr2 mRNA upon iNKT cell develop-
ment. iNKT cells lacking all three miR-17∼92 family clusters (miR-
17∼92, miR-106a∼363, miR-106b∼25) phenocopied both increased
TGF-βRII expression and signaling, and defective effector differen-
tiation, displayed by iNKT Dicer KO cells. Consistently, genetic ab-
lation of TGF-β signaling in the absence of miRNAs rescued iNKT
cell differentiation. These results elucidate the global impact of
miRNAs on the iNKT cell developmental program and uncover
the targeting of a lineage-specific cytokine signaling by miRNAs
as a mechanism regulating innate-like T-cell development and
effector differentiation.
NKT cells | miRNA | TGF-β | development | CD1d
Invariant natural killer T cells (iNKT cells) are T lymphocytesdisplaying innate effector functions that express a semi-invariant
αβ T-cell receptor (TCR), consisting in mice of an invariant Vα14-
Jα18 chain paired with a limited set of diverse Vβ chains (Vβ8.2,
Vβ7, Vβ2) (1). This TCR recognizes self or bacterial lipids pre-
sented by the MHC class I-related molecule CD1d (2). iNKT cells
develop in the thymus from CD4CD8 double positive (DP) precur-
sors that, unlike T cells, are positively selected by CD1d-expressing
DP thymocytes (3). This homotypic interaction delivers strong ag-
onist signals that activate a unique genetic program in iNKT cell
precursors, which leads to their effector maturation in the thymus.
iNKT cell development is characterized in C57BL/6 mice by pro-
gressive maturation stages: immature stage 0 (CD24+CD44lowNK1.1−),
mature naïve stage 1 (CD24−CD44lowNK1.1−), mature effector/
memory stage 2 (CD44hiNK1.1−), and final NK-differentiated stage 3
(CD44hiNK1.1+) (4, 5). This development is accompanied by a re-
markable burst of intrathymic proliferation (stage 0–2), whereas
maturation from stage 2–3 occurs both in the thymus and in the
periphery (4, 5). Through this program, iNKT cells acquire in the
thymus distinct TH1 (iNKT1), TH2 (iNKT2), and TH17 (iNKT17)
effector phenotypes directed by the differential expression of the
master transcription factors T-bet, GATA3, PLZF, and RORγt (6).
The thymic iNKT cell developmental program critically de-
pends upon microRNAs (miRNAs) (7–14). Deletion of Dicer, the
RNase enzyme required for the generation of mature miRNAs, at
the thymic DP stage lead to a dramatic and selective reduction of
iNKT cells, resulting from an almost complete differentiation block
and increased cell death at stage 2 (7). iNKT cells also display a
lineage-specific miRNA profile that is substantially different from
that of T cells, underscoring the uniqueness of the genetic mech-
anisms controlling the development of the two T-lymphocyte
subsets (7). The overall defects observed in Dicer KO iNKT cells
are the combinatorial product of the lack of each single miRNA
that is relevant for their development. By either deletion or over-
expression, miR-150, miR-155, miR-181ab, and Let-7 have so far
been implicated in the regulation of iNKT cells development and
maturation (9–14). The effects of these miRNAs depend critically
on their timing of expression throughout iNKT cell maturation,
underscoring the critical context-dependent regulatory effects of
these molecules (9–14). miR-150 expression increases progressively
from thymic iNKT cell stage 1 to stage 3. miR-150 depletion
or overexpression results in a modest decrease of stage 3 cells,
associated with an up-regulation or down-regulation, respectively,
of the target c-Myb mRNA and increased apoptosis (9, 10). miR-
155 is expressed by stage 1–2 iNKT cells and down-regulated at
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stage 3. miR-155 overexpression results in an increased number of
thymic iNKT cells blocked at stage 2 and an overall reduction in
the periphery, together with deregulated Ets1 and Itk target tran-
scripts (11). miR-181 is expressed at highest levels by thymic im-
mature stage 0 iNKT cells and then progressively declines upon
maturation. miR-181 depletion results in a dramatic reduction of
iNKT cells between stage 0 and 1, increased TCR signaling
threshold, impaired PTEN expression, and regulation of global
metabolic fitness (12, 13). Let-7 expression in thymic iNKT cells
increases from stages 0–3 and plays a critical role in iNKT cell
differentiation by down-regulating the expression of the PLZF
master gene regulator, determining their full terminal effector and
phenotypic maturation (14).
In the present study, we sought to gain further insight into the
role of Dicer-dependent miRNAs in regulating the expression of
genes required for iNKT cell development. Through a combination
of systemic and analytical approaches, we provide a comprehensive
atlas of pathways that are dynamically modulated in developing
iNKT cells under the control of the cell-specific miRNAs, as well as
the evidence for a critical role for tuning transforming growth
factor-β receptor II (TGF-βRII) expression and TGF-β signaling by
miRNAs belonging to the miR-17∼92 family clusters in controlling
iNKT cell ontogeny.
Results
Transcriptional Signature of iNKT Cells Lacking miRNAs. We first char-
acterized the changes in gene expression occurring in iNKT cells
developing in the absence of miRNAs induced by the lack of Dicer
(15). The absence of miRNAs results in an anticorrelated increased
expression of their direct mRNA targets (16, 17), as well as in an
indirect modification of the expression of additional genes con-
nected with them in regulatory networks. Thymic iNKT cells were
sorted from Dicer KO and Dicer WT mice (Fig. 1A). Because of
their paucity, iNKT cells from Dicer KO mice were collected in a
single sample (iNKT KO). iNKT cells from Dicer WT mice were
divided in two samples containing stages 1 and 2 together (iNKT
1–2), corresponding to the maturation attained by Dicer KO iNKT
cells, and stage 3 alone (iNKT 3), respectively (Fig. 1A). Total
mature thymic T cells were also collected. The samples were ana-
lyzed in triplicate and 8,357 genes were expressed in at least 1 of 15
biological samples (Dataset S1). Principal component analysis (18)
performed on the genes expressed in the experiment (Fig. 1B)
showed that iNKT KO cells were close to iNKT 1–2 WT cells, as
expected from their similar maturation stages. iNKT 3 WT cells
segregated from both iNKT KO and iNKT 1–2 WT cells and from
T KO and T WT cells, which grouped together, consistent with the
distinct gene-expression program displayed by developing iNKT
cells. Linear models for microarray data (Limma) analysis with a
5% false discovery rate (FDR) threshold identified the genes dif-
ferentially expressed among the samples analyzed (Dataset S1).
Based on this threshold, T KO cells differed from T WT lympho-
cytes only for 28 genes, confirming the normal phenotype observed
in thymic T cells when Dicer was ablated from the DP stage (7, 15,
19), and were no longer considered in the study. In iNKT cells, a
pairwise comparison of the samples (Fig. 1C) showed that 255
genes were differentially expressed in iNKT KO vs. iNKT 1–2 cells,
whereas 2,023 and 1,362 were differentially modulated in iNKT KO
vs. iNKT 3 cells and iNKT 1–2 vs. iNKT 3 cells, respectively. This
analysis allowed also identified the transcripts that were statistically
up- or down-regulated as a result of: (i) the absence of miRNA
expression (Fig. 1D), (ii) the progressive maturation attained by
iNKT cells (Fig. 1E), and (iii) the likely combination of both
mechanisms (Fig. 1F). The gene-expression profile associated with
the progressive maturation from iNKT 1–2 to iNKT 3 cells was in
good agreement with published datasets (20, 21) (Fig. 1E and Table
S1). The genes that were up-regulated in iNKT KO cells, compared
with WT iNKT cells, were candidates for being direct miRNA
targets (Fig. 1 D and F). A Venn diagram in Fig. 1G depicts the
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Fig. 1. iNKT and T-cell transcriptome in presence or absence of Dicer.
(A) Thymic HSAlow iNKT and TCR-βhigh SP T cells were sorted from 4-wk-old
Dicer KO and Dicer(lox/lox) WT littermate mice. In Dicer WT mice, stages 1
and 2 iNKT cells were pooled together (iNKT 1–2 WT), separated from
stage 3 iNKT cells (iNKT 3 WT). In Dicer KO mice, sorted iNKT cells were
collected in a single sample (iNKT KO cells). (B) Principal component
analysis of microarray data were made on normalized expression levels of
expressed genes in the array (detection P value 0.01 in at least one
sample). A three-dimensional visualization of the first three principal
components is shown. The first three principal components accounted for
the 79% of explained variance and clustered apart samples. (C ) Differ-
entially expressed genes in the indicated samples were analyzed in bi-
ological triplicates of Illumina beadchip arrays. Significantly expressed
genes were identified by Limma analysis with a 5% FDR threshold. The
graph shows the number and percentage of up- and down-modulated
genes in each biological comparison within 8,357 total genes. (D–F )
Volcano plots showing magnitude of change of the genes differentially
expressed in the indicated samples and statistical significance. Genes
represent a subset of the statistically significant differentially expressed
genes. (G) Venn diagram depicting overlapping genes differentially
expressed in the indicated comparisons.
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numbers of private and shared differentially expressed genes
identified in the indicated cell comparisons.
To systematically identify mRNAs potentially modulated by
miRNAs during iNKT cell development, we focused on the 255
transcripts differentially expressed between iNKT KO and iNKT
1–-2 cells. Hierarchical clustering using these 255 transcripts di-
vided the samples into the three expected iNKT KO, iNKT 3 WT,
and iNKT 1–2 WT groups (Fig. 2; gene names are available in Fig.
S1). Moreover, the transcripts clustered in four distinct groups.
Specifically, cluster 1 included genes with higher expression in
iNKT KO cells versus all iNKT WT cells, irrespective of their
developmental stage (Fig. 2A, in black). Cluster 2 (Fig. 2A, in
red) comprised genes with higher expression in both iNKT KO
and iNKT WT 3, compared with iNKT WT 1–2 cells. Cluster 3
(Fig. 2B, in red) included genes down-regulated in both iNKT
KO and iNKT WT 3 cells compared with the iNKT WT 1–2
samples. Finally, cluster 4 (Fig. 2B, in black) contained genes
selectively down-regulated in iNKT KO cells compared with
both iNKT WT 1–2 and 3 samples.
To shed light on the general molecular mechanisms underlying
the defect observed in iNKT cells devoid of Dicer-dependent
miRNAs, we performed a Gene Ontology (GO) term enrichment
analysis on genes differentially expressed between iNKT KO and
iNKT 1–2 WT cells. Clustering together the biological processes
enriched in a statistically significant manner through a semantic
similarities analysis (Fig. S2) emphasized four main groups of GO
categories that can be summarized as: (i) ion homeostasis, (ii) sig-
naling, (iii) development, and (iv) response to stress stimuli. These
GO categories comprise genes related to the metabolic control and
activation of the cells, as ion channels or controllers of the redox
state, as also confirmed by the statistically significant enrichment of
the relative molecular function GO term (GO:0004601 peroxidase
activity, with FDR = 0.00855).
Finally, we matched the 72 miRNAs that we previously reported
to be expressed by thymic iNKT cells (7) with their predicted
targets within the 255 transcripts differentially expressed in iNKT
KO compared with iNKT 1–2 cells. Fig. 2 shows that the majority
of the predicted targets of these miRNAs were up-regulated in
iNKT KO cells, consistent with a role for these miRNAs in
modulating gene expression in iNKT cell development. Indeed,
the 150 genes up-regulated in iNKT KO cells (clusters 1 and 2)
(Fig. 2A) show a significantly greater density of predicted miRNA
binding sites (Fisher test, P = 5.89e-3 and 2.69e-9, respectively)
compared with the 105 transcripts down-regulated in iNKT KO
cells (clusters 3 and 4) (Fig. 2B).
Collectively, these data defined the changes in gene expression
and the resulting defective functional processes, occurring in de-
veloping iNKT cells as a result of the lack of miRNA-dependent
posttranscriptional control.
Systemic Definition of miRNAs and Target Genes Relevant for iNKT
Cell Development. To systemically define the miRNAs that were
putatively involved in controlling the development of iNKT cells,
we first identified the miRNAs whose predicted targets had a
significantly different fold-change compared with nontarget genes,
in the comparison between iNKT KO and iNKT 1–2 cells. This
unbiased approach identified miR-142-3p, miR-181abcd/4262,
miR-30abcdef/30abe-5p/384-5p, miR-19ab, and miR-23abc/23b-3p
(Table 1). Notably, the miR-181abcd/4262 family was already
shown to play a critical role in iNKT cell development (12, 13),
underscoring the likelihood of the selection approach. The ex-
pression of these miRNAs was assessed by quantitative RT-PCR
(qRT-PCR) in the three thymic iNKT cell subsets purified from
WT mice (Fig. S3). miR-142-3p was equally expressed at all three
stages. miR-181a and -b and miR-30e and -c were expressed at a
higher level at stage 1 and down-regulated at stages 2 and 3, as
reported previously (12, 13). miR-23b, miR30-a-5p, and miR-30b
were up-regulated at stage 3. Finally miR-19a and -b, two miRNAs
of the miR-17∼92 family clusters, were selectively up-regulated
at stage 2, the stage at which maturation of Dicer KO iNKT cells
is blocked. To identify potentially relevant targets for these
miRNAs, we matched them against the transcripts that were up-
regulated in Dicer KO iNKT cells (Fig. 2A) and also contained in
the enriched GO categories (Fig. S2). As shown in Table 2, we
obtained a restricted list of genes. We focused on Tgfbr2, one of
the two subunits of the heterodimeric receptor for TGF-β, be-
cause of the known role played by this cytokine in regulating
iNKT cell development. TGF-β is required for protection against
apoptosis, lineage expansion, and maturation of iNKT cells (22).
TGF-β signaling sustains iNKT cell expansion at stage 1, whereas
it acts as a “brake” for differentiating iNKT cells that must be
selectively down-modulated at stage 2 to let their maturation
proceed to stage 3 (22). Tgfbr1, the other subunit of the heter-
odimeric TGF-β receptor, was also up-regulated in iNKT KO
cells (Fig. 2A). We thus posited that the modulation of TGF-β
signaling might result from the miRNA-dependent down-regulation
of Tgfbr2 expression at stage 2. In the absence of miRNAs, the
heterodimeric TGF-β receptor expression would remain high in
stage 2 iNKT cells, resulting in unconstrained TGF-β signaling
that would contribute to their defective development. To test this
hypothesis, we first confirmed the up-regulation of the TGF-βRII
protein on the surface of primary thymic iNKT KO compared with
WT iNKT 1–2 cells (Fig. 3A). Second, we verified that TGF-βRII
up-regulation was also associated with an amplified intracellular
signaling, as shown by the increased phosphorylation of the TGF-
β–dependent transcription factors Smad2/3 (23) in primary iNKT
KO cells (Fig. 3B).
Together, these systemic analyses highlighted miRNA/mRNA
pairs that might play a role in regulating iNKT cell development
and suggested that a deregulated miRNA-dependent fine-tuning
of TGF-β signaling, via defective TGF-βRII expression at stage 2,
would be one of the mechanisms contributing to the altered iNKT
cell development in Dicer KO mice.
Identification of the miRNAs Regulating TGF-βRII Expression in
Developing iNKT Cells. To identify the miRNAs potentially in-
volved in the posttranscriptional control of TGF-βRII, we de-
termined in the three thymic iNKT cell stages the anticorrelated
expression between Tgfbr2 mRNA (Fig. 4A) and the miRNAs
expressed by iNKT cells that were predicted to target this transcript
(Fig. 4 B–D). The majority of the predicted miRNAs belonged to
the miR-17∼92 family, made of the three paralog miR-17∼92,
miR-106a∼363, and miR-106b∼25 clusters (24) (Fig. 4E). These
highly redundant clusters comprise 15 miRNAs that form four
“seed” families: the miR-17, miR-18, miR-19, and miR-92 families.
Two sequences in the 3′UTR of Tgfbr2 mRNA are experimentally
validated targets for all eight miRNAs belonging to the miR-17 and
miR-19 families (25–28). The independent miR-21 and miR-23b
were also predicted to target Tgfbr2 mRNA. However, only the
expression of the predicted miR-17, miR-19a, miR-19b, miR-20a,
miR-20b, miR-93, miR-106a, and miR-106b peaked at stage 2 and
perfectly anticorrelated with Tgfbr2 mRNA expression (Fig. 4 C
and D). Notably, the miR-17 seed family (miR-17, miR-20a, miR-
20b, miR-93, miR-106a, and miR-106b) on the one hand, and the
miR-19 seed family (miR-19a and miR-19b) on the other hand,
targeted the same sequences in the 3′UTR of Tgfbr2 mRNA, re-
spectively (Fig. 4B), suggesting a high level of redundancy in the
posttranscriptional regulation (29). Consistent with the coordinated
expression of the three miR-17∼92 family clusters as polycistronic
precursors undergoing posttranscriptional processing, the other
members of these clusters (miR-18a, miR-18b, miR-92a, miR-25,
miR-363) also displayed a comparable expression peak at stage 2 in
thymic iNKT cells (Fig. 4C); however, they were not predicted to
target Tgfbr2 transcript.
E8288 | www.pnas.org/cgi/doi/10.1073/pnas.1612024114 Fedeli et al.
21
0
-1
-2
A B
mi
R.
30
ab
cd
ef.
30
ab
e.5
p.3
84
.5p
mi
R.
18
1a
bc
d.4
26
2
mi
R.
19
ab
mi
R.
15
ab
c.1
6.1
6a
bc
.19
5.3
22
.42
4.4
97
.19
07
mi
R.
12
8.1
28
ab
mi
R.
26
ab
.12
97
.44
65
mi
R.
34
ac
.34
bc
.5p
.44
9.a
bc
.44
9c
.5p
mi
R.
29
ab
cd
mi
R.
23
ab
c.2
3b
.3p
mi
R.
14
2.3
p
mi
R.
49
5.1
19
2
mi
R.
22
3
mi
R.
21
.59
0.5
p
mi
R.
49
4
mi
R.
29
0.5
p.2
92
.5p
.37
1.5
p.2
93
mi
R.
24
.24
ab
.24
.3p
mi
R.
45
1
let
.7.
98
.44
58
.45
00
mi
R1
7.1
7.5
p.2
0a
b.2
0b
.5p
.93
.10
6a
b.4
27
.51
8a
.3p
.51
9d
iN
K
T 
1-
2 
W
T
iN
K
T 
3 
W
T
iN
K
T 
K
O
3 1 2 31 2 31 2 mi
R.
30
ab
cd
ef.
30
ab
e.5
p.3
84
.5p
mi
R.
18
1a
bc
d.4
26
2
mi
R.
19
ab
mi
R.
15
ab
c.1
6.1
6a
bc
.19
5.3
22
.42
4.4
97
.19
07
mi
R.
12
8.1
28
ab
mi
R.
26
ab
.12
97
.44
65
mi
R.
34
ac
.34
bc
.5p
.44
9.a
bc
.44
9c
.5p
mi
R.
29
ab
cd
mi
R.
23
ab
c.2
3b
.3p
mi
R.
14
2.3
p
mi
R.
49
5.1
19
2
mi
R.
22
3
mi
R.
21
.59
0.5
p
mi
R.
49
4
mi
R.
29
0.5
p.2
92
.5p
.37
1.5
p.2
93
mi
R.
24
.24
ab
.24
.3p
mi
R.
45
1
let
.7.
98
.44
58
.45
00
mi
R1
7.1
7.5
p.2
0a
b.2
0b
.5p
.93
.10
6a
b.4
27
.51
8a
.3p
.51
9d
3 1 2 31 2 31 2
iN
K
T 
1-
2 
W
T
iN
K
T 
3 
W
T
iN
K
T 
K
O
Fig. 2. Genes differentially expressed between KO iNKT cells and stage 1–2 WT iNKT cells. The heatmaps of the hierarchical clustering of the 255 genes
differentially expressed between iNKT KO cells and stage 1–2 iNKT WT cells with adjusted P < 0.05 (Benjamini correction). Red in the red/blue scale color
indicates higher expression. (A) The heatmap contains the genes up-regulated either in iNKT KO cells compared with both iNKT 3 and iNKT 1–2 WT samples
(black cluster), or in both iNKT KO and iNKT 3 WT cells compared with iNKT 1–2 WT ones (red cluster). Solid boxes on the right show predicted targeting of the
3′UTR contained in each gene by the miRNAs (grouped by families) expressed by thymic iNKT cells. Black or red boxes indicate one or two miRNA seeds in the
3′UTR of the target gene, respectively. (B) The heatmap contains the genes that are down-regulated either in both iNKT KO and iNKT 3 WT cells compared
with iNKT 1–2 WT cells (red cluster), or in iNKT KO cells compared with both iNKT 3 and iNKT 1–2 WT cells (black cluster). Solid boxes on the right show the
predicted miRNA targeting of each differentially expressed gene as in A.
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miRNAs of the miR-17∼92 Family Clusters Regulate TGF-β Signaling in
iNKT Cell Development. To validate the role of the predicted and
anticorrelated miRNAs in the control of iNKT cell development
through the regulation of the Tgfbr2 transcript, we analyzed mice in
which the genes encoding all of the three paralog miR-17∼92,
miR-106a∼363, and miR-106b∼25 clusters were deleted (29) to
overcome the targeting redundancy of the these mRNA families
(29). In triple KO (TrKO) mice, the 106a∼363 and miR-106b∼25
clusters were eliminated in the germ line, and an inducible
knocked-in miR-17∼92 cluster was deleted at the DP thymocyte
stage by crossing with CD4-Cre transgenic mice (29). Gross thy-
mocytes and detailed iNKT cell development in TrKO, Dicer KO
and WT animals were compared. Total thymocyte numbers were
reduced by 30% in TrKO mice compared with WT or Dicer KO
animals, because of a reduction in DP thymocytes resulting from
increased apoptosis of heat stable antigen (HSA)high cells. How-
ever, mature single positive (SP) thymocyte numbers were normal
in TrKOmice (CD4+ 1.2 × 107± 1 × 106, CD8+ 4.4 × 106 ± 5 × 105),
and comparable to both Dicer KO (CD4+ 1.2 × 107 ± 1 × 106,
CD8+ 4.3 × 106 ± 4.5 × 105) and WT (CD4+ 1.4 × 107 ± 9 × 105,
CD8+ 4.2 × 106 ± 3 × 105) mice, confirming that the triple miRNA
gene deletion did not perturb mature T cells (30). In contrast, both
percentage and number of thymic iNKT cells in TrKO mice were
markedly reduced, similar to those of Dicer KO mice (Fig. 5 A and
B). This result was because of a decreased proliferation of TrKO
iNKT cells compared with the WT ones, whereas cell death was
comparable (Fig. S4). Of note, the residual thymic TrKO iNKT
cells displayed a significant reduction of mature stage 3 cells (Fig. 5
A and C), comparable to the defect found in the absence of Dicer.
TGF-βRII expression level doubled in thymic TrKO iNKT cells
compared with WT ones, approaching the level of Dicer KO iNKT
cells (Fig. 5D) and in line with the expected extent of miRNA-
mediated repression, which rarely exceeds twofold (31). Consistent
with the high target redundancy of these miRNAs, we detected the
most profound iNKT cell developmental defect (Fig. S5 A and B),
with the highest TGF-βRII expression level (Fig. S5C) in the TrKO
mice, compared with either miR-17∼92/miR-106b∼25 or miR-
106a∼363/miR-106b∼25 double KO combinations. The higher
TGF-βRII expression was also similarly associated with increased
signaling, as assessed by increased pSMAD2/3 levels (Fig. 5E). This
result occurred in the face of normal Tgfb1 mRNA expression
levels, detected by qRT-PCR in the whole thymocyte population of
Table 1. Identification of miRNAs potentially involved in controlling iNKT cell development
miRNA family* FC targets† FC nontargets† P FDR
miR-142–3p −0.11 0.00 2.8e-11 3.5e-09
miR-181abcd/4262 −0.06 0.00 6.9e-11 4.8e-09
miR-30abcdef/30abe-5p/384–5p −0.04 0.00 1.6e-06 2.4e-05
miR-19ab −0.04 0.00 4.5e-05 0.00043
miR-23abc/23b-3p −0.04 0.00 0.00023 0.002
P value (P) and FDR relate to the comparison between iNKT 1–2 WT and iNKT KO cells.
*miRNAs potentially involved in controlling iNKT cell development (see Materials and Methods).
†Fold-change (FC). Table lists the logarithmic FC in the genes predicted or not predicted to be targeted by the
miRNA analyzed in the comparison between iNKT 1–2 WT and iNKT KO cells. The comparison between FCs was
performed with a Mann–Whitney u test.
Table 2. miRNAs and their targets predicted to be involved in iNKT cell development
miRNA Gene ID Gene symbol Gene name and function
miR-30abcdef/30abe-5p/384–5p 329165 Abi2 Abl-interactor 2 signals downstream of activated Rac in the regulation
of actin polymerization
miR-181abcd/4262 11804 Aplp2 Amyloid β (A4) precursor-like protein 2 modulates
phosphoinositide-mediated calcium flux
miR-181abcd/4262 11931 Atp1b1 ATPase, Na+/K+ transporting, β 1 polypeptide catalyzes the hydrolysis
of ATP coupled with the exchange of Na+ and K+ ions
miR-181abcd/4262 23849 Klf6 Kruppel-like factor 6 is a transcriptional activator
miR-19ab 23849 Klf6
miR-181abcd/4262 17158 Man2a1 Mannosidase 2, α 1 catalyzes the first step in the biosynthesis of
complex N-glycans
miR-181abcd/4262 56045 Samhd1 SAM domain and HD domain, 1 is a dGTP-activated dNTPase that has
been implicated as a modulator of the innate immune response
miR-142–3p 20393 Sgk1 Serum/glucocorticoid regulated kinase 1 is a salt-sensing
serine-threonine kinasemiR-19ab 20393 Sgk1
miR-23abc/23b-3p 20393 Sgk1
miR-495/1192 20393 Sgk1
miR-19ab 21813 Tgfbr2 Transforming growth factor, beta receptor II is one of the two
coreceptors for TGF-βmiR-23abc/23b-3p 21813 Tgfbr2
miR-19ab 21858 Timp2 Tissue inhibitor of metalloproteinase 2 complexes with
metalloproteinases, irreversibly inactivating themmiR-30abcdef/30abe-5p/384–5p 21858 Timp2
miR-495/1192 21858 Timp2
miR-181abcd/4262 105245 Txndc5 Thioredoxin domain containing 5 is endowed with thioredoxin activity
and functions as antioxidant by facilitating the reduction of other
proteins
Shown are the predicted targets of the microRNAs families (listed in Table 1) up-regulated in Dicer KO iNKT cells and involved in the biological processes
identified by the GO enrichment analysis.
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TrKO and Dicer KO mice and comparable to that of WT thy-
mocytes (Fig. S6). Culturing thymocytes with TGF-β1 evoked a
greater increase in pSMAD2/3 level in TrKO (+37%) compared
with WT iNKT cells (+18%), consistent with their increased TGF-
βRII expression (Fig. 5F). These results supported a direct role for
the higher TGF-βRII expression, resulting from the lack of miRNAs,
in determining the increased pSMAD2/3 levels exhibited by
TrKO iNKT cells.
We next wondered whether the expression of targets of TGF-β
signaling was altered in TrKO iNKT cells. The expression of
several genes that are either transcriptionally repressed (Tbx21-
Tbet, Gata3, Myc) (32–34) or induced (Cdkn1a-p21, Cdkn2b-p15,
Bcl2l11-Bim, Sgk1, Fos, Jun) (35–39) by TGF-β signaling was
assessed in stages 1, 2, and 3 WT and TrKO iNKT cells. All
transcripts displayed the expected up- or down-regulation at stage
2, resulting from an increased TGF-β signaling, compared with the
WT pattern (Fig. S7), with the exception of Bcl2l11-Bim.
TGF-β signaling is also implicated in the differentiation of the
iNKT cell subset displaying TH17 effector functions (iNKT17)
that, together with iNKT cells displaying TH1 (iNKT1) and TH2
(iNKT2) effector functions, are generated in the thymus. We thus
investigated the effects of deleting miRNAs in development of the
three iNKT cell subsets in Dicer KO and TrKO mice compared
with WT animals. Dicer KO and TrKO mice displayed a sig-
nificant increase of iNKT2 cells and decrease of iNKT1 and,
particularly of iNKT17 cells, which were completely absent in
thymic iNKT cells from the two KO mice (Fig. 5 G and H). The
down-regulation of the iNKT17 RORγt protein in Dicer KO
iNKT cells, compared with WT iNKT 1–2 cells, confirmed the
microarray data (Fig. 2A). Moreover, this skewing toward the
iNKT2 subset was detected also in the thymus, spleen, liver, and
lymph nodes of older (8-wk-old) TrKO mice (Fig. S8), suggesting
that this defect is not the result of a delayed iNKT cell develop-
ment but rather of a diversion of their effector maturation.
Taken together, these results identified miRNAs belonging to
the miR-17 and miR-19 seed families, which are part of the miR-
17∼92 family clusters, as critical regulators of TGF-βRII expres-
sion in developing iNKT cells, and supported a role for these
paralog miRNAs in directing iNKT cell effector differentiation via
fine-tuning of TGF-β signaling at stage 2.
Genetic Complementation Experiments Support miRNA-Dependent
Modulation of TGF-β Signaling in iNKT Cell Development. Because
the above results suggested that the deletion of the three miRNA
families resulted in deregulated TGF-β signaling and altered
iNKT cell development, we sought to undertake a genetic com-
plementation approach to assess whether the deletion of TGF-
βRII expression from miRNA-deficient iNKT cells would restore
their correct maturation. In these mice, the lack of TGF-βRII
expression in developing iNKT cells would counteract the in-
creased TGF-β–dependent signaling resulting from the lack of
miRNA-mediated regulation. Given the complexity of breeding
TrKO and TGF-βRII KO mice to obtain animals with four ho-
mozygous knockout genes, and the fact that TGF-βRII and TGF-
β–dependent signaling were up-regulated in iNKT cells from
Dicer KO mice as well, we simplified the experiment by crossing
Dicerfl/fl (Dicer KO) and TGF-βRIIfl/fl (TGF-βRII KO) mice, in
which both genes are deleted at the DP stage by CD4-Cre. Thymic
iNKT cells were analyzed from 2-wk-old mice before TGF-βRII
KO animals develop fulminant autoimmunity (40). In line with
published data (22), TGF-βRII KO mice displayed reduced per-
centage and number of iNKT cells (Fig. 6 A and B) and an in-
creased frequency in iNKT stage 3 cells (Fig. 6 C and D)
compared with WT animals, consistent with the role of TGF-β
signaling in sustaining iNKT cell stage 1 expansion and inhibiting
stage 3 maturation. Comparable reductions in iNKT cell per-
centage and number were also found in Dicer KO mice; however,
they were accompanied by the expected maturation block at stage
2. In Dicer–TGF-βRII double KO mice, frequency and numbers
of iNKT cells remained low (Fig. 6 A and B). Remarkably, how-
ever, iNKT cell maturation to stage 3 was completely restored,
with a distribution throughout the stages more similar to that of
WT iNKT cells than to those displayed by single TGF-βRII or
Dicer KO cells (Fig. 6 C and D).
Collectively, these findings further support the concept that the
expression of TGF-βRII must be specifically tempered by miRNAs
at stage 2 of iNKT cell development to deliver the appropriate
level of TGF-β signaling for their correct maturation.
Discussion
Our systemic analysis gains insight into the molecular pathways
regulated by miRNAs during iNKT cell development. Dicer KO and
WT stage 1–2 iNKT cells differed for the expression of 255 genes
belonging to signaling, development, response to stress stimuli, and
ion homeostasis ontology categories, which contain genes involved
in the regulation of cell metabolism, ion channels, and redox state of
the cells. This finding is consistent with the agonist selection that
iNKT cells undergo in the thymus, unlike T cells, resulting in pro-
liferation and differentiation that likely require these gene cate-
gories. Most of the 72 miRNA expressed by iNKT cells (7) were
predicted to target transcripts that were up-regulated in Dicer KO
iNKT cells, among the 255 differentially expressed ones, suggesting
that they may be miRNA targets. In addition to the already de-
scribed miR-181abcd/4262 family (12, 13), we identify miRNAs
(namely miR-142–3p, miR-30abcdef/30abe-5p/384-5p, miR-19ab,
and miR-23abc/23b-3p) that might regulate transcripts relevant for
the development of these cells. We validated this prediction by fo-
cusing on the miR-19ab/Tgfbr2 targeting pair, because TGF-β reg-
ulates thymic iNKT cell expansion at stage 1 and final maturation to
stage 3 (22). This process requires the selective down-regulation of
TGF-βRI and -II expression on iNKT cells at stage 2 (22). Our data
suggest that modulation of TGF-βR expression at iNKT cell stage 2
is likely to occur through the action of miRNAs belonging to the
miR-17 and miR-19 seed families, which are part of the three
paralog miR-17∼92, miR-106a∼363, and miR-106b∼25 clusters.
The miR-17 seed family is contained in all of the three clusters,
whereas the miR-19 seed family is present in the two miR-17∼92
and miR-106a∼363 clusters. miR-17-5p, miR-19b, miR-20, and
miR-93 are expressed at the highest levels in iNKT cell stage 2,
suggesting that they might be the ones modulating Tgfbr2 mRNA
expression at this critical stage. The redundancy by which different
miRNAs control the level of Tgfbr2mRNA expression underscores
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the critical requirement for the tuning of TGF-β–dependent
signaling for iNKT cell differentiation, as also shown in other cell
types (41–43). Furthermore, our data also highlight a critical con-
nection between the timing of miRNA expression during iNKT cell
maturation and their stage-dependent and selective function. All
eight paralog miRNAs involved in the modulation of TGF-βRII
expression are coordinately up-regulated at iNKT cell stage 2, even
though with quantitative differences between them, resulting in the
stage-dependent TGF-βRII expression regulation.
In TrKO iNKT cells, in addition to increased TGF-βRII expres-
sion and signaling, the mRNA expression level of several TGF-β
transcriptional targets showed an up- or down-regulation at stage 2,
which was consistent with the increased TGF-β signaling. Although
some of these transcripts (Cdkn1a, Cdkn2b, Bcl2l11, and Sgk1) were
also predicted to be targeted by miRNAs belonging to the three
paralog clusters, they were either down-regulated in TrKO iNKT
cells (i.e., Bcl2l11) or not significantly up-regulated in T cells that
also lacked the three miRNA clusters, suggesting that their up-
regulation in TrKO iNKT cells should likely results from the increased
TGF-β signaling rather than from the lack of miRNA targeting.
TGF-β signaling is also specifically required for the thymic dif-
ferentiation of the recently described RORγt+ iNKT17 cell subset
(23). However, these cells were absent in both Dicer KO and TrKO
animals, in which TGF-β signaling is increased. This observation
underscores the requirement for a fine-tuned TGF-βRII expression
by miRNAs to deliver the appropriate amount of TGF-β signaling
that canalizes iNKT17 differentiation. A similar regulation of other
critical targets that are involved in iNKT cell development has been
observed for the Let-7 miRNA family, whose absence in mice re-
sults in the sustained overexpression of PLZF, which impairs
iNKT1 development and leads to the preferential differentiation of
iNKT cells into the iNKT2 and iNKT17 subsets (14). Interestingly,
both in Dicer KO and in TrKO mice, the development and mat-
uration of the residual iNKT cells was highly skewed toward the
iNKT2 subset, with a marked reduction of iNKT1 cells, suggesting
that TGF-β signaling may also take part in the developmentally
regulated differentiation of all three mouse iNKT cell subsets.
Nevertheless, although the targeting of TGF-βRII by the miRNAs
of the three paralog clusters is compelling, we cannot discount the
possibility that additional mechanisms may be operative in the
TrKO mice, given their marked phenotype and the breadth of
transcripts potentially targeted by this extended miRNA family.
Up to now, miR-150, miR-155, miR-181ab, and Let-7 were shown
to play a role in iNKT cell development (9–14). Their depletion
from iNKT cells results in defects that partially recapitulate those
observed in Dicer KO animals and affects the specific maturation
stage at which each miRNA is expressed. This context-dependent
expression is crucial to determine their differential effects on iNKT
cell development. For example, the expression of miR-181 (12, 13)
peaks in the initial phases of iNKT cell ontogenesis (iNKT stages
0–1) and declines upon maturation. miR-181a1b1 KOmice display a
dramatic drop in the total number of iNKT cell in the thymus with
an increased frequency of stage 0 cells, because of the accumulation
of immature cells. However, the remaining iNKT cells proceed
unconstrained through maturation to stage 3. miR-181a1b1 control
TCR signaling and metabolic fitness that are critical to support the
early stage of iNKT cell development, but seem dispensable for their
final maturation. In contrast, the expression of miR-17-92, miR-
106a-363, and miR-106b-25 clusters peaks at stage 2, later than that
of miR-181a1b1. As a result, depletion of the miR-17-92 family
clusters results in defects in the iNKT cell final maturation because
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of the altered expression of TGF-βRII, whereas the early stages are
normal. Therefore, we propose that the iNKT cell defect we found
in Dicer KO mice is the sum of the lack of all of the miRNAs
identified so far: miR-181ab control the initial part of iNKT cell
ontogenesis, whereas miR-17-92 family clusters direct the final steps
of iNKT cell maturation.
In conclusion, our study highlights the prominent molecular
pathways that are dynamically modulated in developing iNKT
cells under the control of the cell-specific miRNAs, and suggests a
critical role of tuning TGF-βRII expression and TGF-β signaling
by members of the miR-17∼92 family clusters in iNKT cell de-
velopment, maturation, and functional differentiation.
Materials and Methods
Mice. C57BL/6(N) (Charles River), Dicerfl/fl and CD4-Cre Dicerfl/fl (KO) (7, 15), miR-
106a∼363−/−miR-106b∼25−/− CD4-Cre miR-17∼92fl/fl mice (29) were housed in a
pathogen-free environment. Procedures involving animals were approved by
the Institutional Animal Care and Use Committee at the San Raffaele Scientific
Institute in Italy (IACUC no. 678).
Cell Staining and Flow Cytometry. Total thymocytes were stained with anti-
CD24/HSA, CD4, CD44, NK1.1, TCR-β, CD69 (Biolegend); anti–TGF-βRII (R&D
Systems); anti–p-SMAD2/3 (sc-11769) (Santa Cruz), followed by swine anti-goat
IgG (Southern Biotech); anti-RORγt and anti-PLZF Abs (e-Bioscience), all in the
presence of rat anti-mouse CD16/CD32 Fc Blocker 2.4G2 mAb. iNKT cells were
identified by PBS-57 loaded mCD1d-PE tetramers (NIH Tetramer Facility). BrdU
staining was performed using BrdU Flow Kits (BD Biosciences). Apoptosis was
detected by fluorescent CaspACE FITC-VAD-FMK (Promega). Where indicated,
cells were stimulated for 30 min at 37 °C with αCD3/CD28 beads (Dynabeads
Mouse T-Activator CD3/CD28, Gibco) at a 1 cell:3 beads ratio ± 3 ng/mL human
recombinant TGF-β1 (R&D Systems). Dead cells and doublets were excluded
with DAPI staining and physical gating. Intracellular staining was performed
using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience). Samples
were acquired on FACSCantoII flow cytometer (BD Biosciences) and data an-
alyzed by FlowJo software (TreeStar).
Isolation and Purification of Cells by Sorting. Cells were labeled with mAbs and
CD1d-tetramers and subsequently sorted using a MoFlo cell sorter (Beck-
manCoulter). Cell debris and doublets were excluded. The purity of sorted
fractions was checked by flow cytometry reanalysis.
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Fig. 5. Defective iNKT cell maturation in miR-17∼92, miR-106a∼363, and miR-106b∼25 triple KO mice. Thymic iNKT cells from 4-wk-old WT, Dicer KO and TrKO mice
were stained with the indicated mAbs and analyzed by flow cytometry. (A) Shown are the percentages of iNKT cells, subdivided in stage 1, 2, or 3 on the basis of CD44
and NK1.1 expression. (B) Frequency and absolute number of total iNKT cells or (C) stage 1, 2, and 3 iNKT cells from the indicated mice. (D) Expression of TGF-βRII or
(E) Intracellular p-SMAD2/3 in iNKT cells of the indicated mice. Gray filled histograms represent FMO staining controls or, in the case of p-SMAD2/3, the staining of the
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RNA Extraction and Amplification. Total RNA from sorted cells was isolated
with the miRvana kit (Ambion) and quantified by NanoDrop spectropho-
tometer (Thermo Scientific). RNA quality and integrity were verified by an
Agilent 2100 Bioanalyzer profile using Agilent RNA 6000 Pico or Nano kits.
Quantitative Real-Time RT-PCR. miRNA-specific reverse transcription was per-
formed using TaqManMicroRNA Reverse Transcription kit (Applied Biosystems).
qRT-PCR was performed using TaqMan MicroRNA Assay Mix containing PCR
primers and TaqMan probes (Applied Biosystems). Expression values were
normalized to snoRNA-202. For mRNA expression, RNA was amplified with a
MessageAmp RNA Amplification Kit (Ambion) and reverse transcription was
performed with RNA and a High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems). qRT-PCRwas performed in triplicatewith 10–100 ng cDNA/
reaction using Taqman technology (Applied Biosystems) on an ABI Prism 7900
cycler (95 °C for 15 s and 60 °C for 1 min, 40 cycles) and analyzed with SDS 2.2.1
software. HPRT was used as a housekeeping gene. The relative quantification of
gene expression was determined by comparative Ct method.
Gene-Expression Profiling.Mature HSAlow-enriched thymic iNKT cells and T cells
were sorted from 4-wk-old Dicer KO mice and Dicer WT mice. iNKT cells from
Dicer WT were subdivided into stage 1–2 cells (HSAlowTCRβ+CD1dtet+NK1.1−) or
stage 3 cells (HSAlowTCR-β+CD1dtet+ NK1.1+CD44+), whereas Dicer KO iNKT
cells were sorted in toto (HSAlowTCR-βhighCD1dtet+). SP T cells, both from Dicer
KO and Dicer WT mice, were sorted as pooled HSAlowTCR-βhigh CD4 and CD8 SP
cells. All of the five samples were sorted in triplicate, from a pool of 20 mice per
replicate. Total RNA was extracted from the 15 samples, retrotranscribed, am-
plified, and biotinylated with the Illumina Totalprep RNA Amplification kit
(Ambion). Amplified cRNA integrity was checked by an Agilent 2100 Bio-
analyzer profile with Agilent RNA 6000 Nano kit. Washing, staining, and hy-
bridization were performed according to the standard Illumina protocol with
750 ng of cRNA of each sample hybridized onto Illumina Sentrix beadchip ar-
rays Mouseref-8v2. Hybridization and scanning were performed on an Illumina
iScan System and data were processed with GenomeStudio software (Illumina).
Statistical Analysis. All statistical tests were conducted with GraphPad Prism.
Comparisons between two groupswere donewith the two-tailed Student t test
for unpaired samples, applying correction for unequal variances when re-
quired. Comparisons between three or more groups were done with the one-
way ANOVA test plus the Tukey posttest. For all tests, a value of P < 0.05 was
considered significant.
Bioinformatic Analyses. Arrays were quantile-normalized, with no background
subtraction, and expression profiles were obtained for 18,138 genes. Of these,
8,357 genes whose intensity value was significantly different from the back-
ground (detection P < 0.01) in at least one sample of the entire series were
considered “expressed” and included in the analysis. Principal component
analysis was performed on expressed genes using the “mixOmics” (44) R
library (45). The “Limma” Bioconductor package (46) was used to extract
differentially expressed genes with an FDR of 5%. A biological term en-
richment analysis using the GO biological process or molecular function
database was performed using the DAVID tool (47, 48), comparing the
prevalence of gene annotations among differentially expressed genes in
specific contrasts to their prevalence in a background defined by all genes
expressed in at least one iNKT sample. To focus on GO categories specifi-
cally related to differential expression, rather than to the cellular context,
we performed the same analysis comparing the list of expressed genes to a
background defined by all genes represented on the array and discarded
the annotation terms that were enriched in this second comparison. The
GOSemSim package (49) was used to calculate semantic distances among
GO terms and the results used for hierarchical clustering: each of the
clusters thus obtained represents a set of closely related, enriched GO
annotations. The data are deposited in the National Center for Bio-
technology Information’s Gene Expression Omnibus (50) and accessible
through GEO Series accession no. GSE79901.
miRNA target predictions were downloaded from TargetScan v6.1 (51). For
each sample comparison, and each miRNA family included in Targetscan, we
asked whether the predicted targets of each miRNA family expressed by thymic
iNKT cells and included in Targetscan had significantly different fold-change
compared with all other genes. The query was limited to genes that were
predicted targets of at least one miRNA. The comparison between fold-changes
was performed with a Mann–Whitney u test. No explicit selection of differen-
tially expressed genes was used in this analysis (all fold-change values are in-
cluded in the analysis).
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Fig. S3. Expression levels of miRNAs potentially involved in controlling iNKT cells among the three developmental stages. Total RNA was extracted from stage
1, 2, 3 iNKT cells that were sorted from HSAlow thymocytes of 4-wk-old C57BL/6 WT mice and submitted to qRT-PCR using oligonucleotides specific for miRNAs
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Fig. S5. TrKO mice display the most profound iNKT cell developmental defect compared with either miR-17∼92/miR-106b∼25 or miR-106a∼363/miR-106b∼25
double KO combinations. Thymic iNKT cells from 4-wk-old WT, Dicer KO, miR-17∼92/miR-106b∼25, miR-106a∼363/miR-106b∼25, and TrKO mice were analyzed
by flow cytometry. (A) Percentages of iNKT cells among HSAlow thymocytes. (B) Percentages of iNKT cells subdivided in stage 1, 2, or 3 based on CD44 and NK1.1
expression. (C) Expression of TGF-βRII in iNKT cells of the indicated mice. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001 by Student t test.
Fedeli et al. www.pnas.org/cgi/content/short/1612024114 3 of 7
tg
fb
1
n
or
m
al
iz
e
d
ex
pr
es
si
on
W T D icer K O TrKO
0
2
4
6
Fig. S6. Tgfb1 expression is conserved in Dicer KO and TrKO thymocytes. RNA was extracted from single-cell suspensions obtained from thymi of WT, Dicer
KO, and TrKO mice. qRT-PCR with Tgfb1-specific oligonucleotides was performed with Taqman assay; Hprt was used as endogenous control. Differences in
gene expression between the three mouse strains were not statistically significant. Each symbol represents an independent mouse.
Fig. S7. TGF-β–dependent targets are specifically modulated at stage 2 in TrKO mice iNKT cells. Total RNA was extracted from thymic stage 1, 2, and 3 iNKT
cells and T cells that were sorted from 4-wk-old C57BL/6N WT or TrKO mice. Expression of indicated transcriptional targets of TGF-β signaling was assessed by
qRT-PCR and depicted as fold-change value in TrKO iNKT cells compared with WT T cells or iNKT cells of the same stage (horizontal value 1). (A) Expression of
targets expected to be transcriptionally down-regulated by TGF-β signaling. (B) Expression of targets expected to be transcriptionally up-regulated by TGF-β
signaling. Data are representative of three experiments with pools of 10 mice per experiment. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001 by Student t test.
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Fig. S8. iNKT cells are skewed toward the iNKT2 subset. (A) iNKT1, iNKT2, and iNKT17 subsets identified by intranuclear staining for PLZF and RORγt in the
thymus, spleen, liver, and lymph nodes (LN) of 8-wk-old WT and TrKO mice. (B) Percentages and absolute numbers of iNKT1, iNKT2, and iNKT17 subsets
identified in A. Data are representative of two to three experiments with three to four individual mice each. Histograms and plots in B represent mean ± SD;
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001 by ANOVA test.
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Table S1. Comparison with IMMGEN gene expression data
Gene ID Gene symbol Gene Regulation
12043 Bcl2 B-cell leukemia/lymphoma 2 Up
74007 Btbd11 BTB (POZ) domain containing 11 Up
20304 Ccl5 chemokine (C-C motif) ligand 5 Up
12481 Cd2 CD2 antigen Up
12516 Cd7 CD7 antigen Up
12550 Cdh1 Cadherin 1 Up
12700 Cish Cytokine inducible SH2-containing protein Up
13143 Dapk2 Death-associated protein kinase 2 Up
19252 Dusp1 Dual specificity phosphatase 1 Up
98952 Fam102a Family with sequence similarity 102, member A Up
14103 Fasl Fas ligand (TNF superfamily, member 6) Up
74558 Gvin1 GTPase, very large IFN inducible 1 Up
15019 H2-Q8 histocompatibility 2, Q region locus 8 Up
15978 Ifng IFN-γ Up
15979 Ifngr1 IFN-γ receptor 1 Up
16185 Il2rb Interleukin 2 receptor, β chain Up
16477 Junb Jun-B oncogene Up
16628 Klra10 Killer cell lectin-like receptor subfamily A, member 10 Up
17059 Klrb1c Killer cell lectin-like receptor subfamily B member 1C Up
27007 Klrk1 Killer cell lectin-like receptor subfamily K, member 1 Up
17067 Ly6c1 Lymphocyte antigen 6 complex, locus C1 Up
17916 Myo1f Myosin IF Up
107607 Nod1 Nucleotide-binding oligomerization domain containing 1 Up
50778 Rgs1 Regulator of G protein signaling 1 Up
20849 Stat4 Signal transducer and activator of transcription 4 Up
57765 Tbx21 T-box 21 Up
107769 Tm6sf1 Transmembrane 6 superfamily member 1 Up
22041 Trf Transferrin Up
14605 Tsc22d3 TSC22 domain family, member 3 Up
330192 Vps37b Vacuolar protein sorting 37B (yeast) Up
16963 Xcl1 Chemokine (C motif) ligand 1 Up
68026 2810417H13Rik RIKEN cDNA 2810417H13 gene Down
11669 Aldh2 Aldehyde dehydrogenase 2, mitochondrial Down
11983 Atpif1 ATPase inhibitory factor 1 Down
11799 Birc5 Baculoviral IAP repeat-containing 5 Down
12520 Cd81 CD81 antigen Down
14793 Cdca3 Cell division cycle associated 3 Down
66953 Cdca7 Cell division cycle associated 7 Down
12709 Ckb Creatine kinase, brain Down
13167 Dbi Diazepam binding inhibitor Down
13482 Dpp4 Dipeptidylpeptidase 4 Down
14775 Gpx1 Glutathione peroxidase 1 Down
319173 Hist1h2af Histone cluster 1, H2af Down
319169 Hist1h2ak Histone cluster 1, H2ak Down
319170 Hist1h2an Histone cluster 1, H2an Down
665433 Hist1h2ao Histone cluster 1, H2ao Down
360198 Hist1h3a Histone cluster 1, H3a Down
16010 Igfbp4 Insulin-like growth factor binding protein 4 Down
50905 Il17rb Interleukin 17 receptor B Down
16189 Il4 Interleukin 4 Down
110033 Kif22 Kinesin family member 22 Down
19141 Lgmn Legumain Down
16906 Lmnb1 Lamin B1 Down
16911 Lmo4 LIM domain only 4 Down
17035 Lxn Latexin Down
17218 Mcm5 Minichromosome maintenance deficient 5, cell division
cycle 46 (Saccharomyces cerevisiae)
Down
52033 Pbk PDZ binding kinase Down
54132 Pdlim1 PDZ and LIM domain 1 (elfin) Down
233406 Prc1 Protein regulator of cytokinesis 1 Down
19366 Rad54l RAD54 like (S. cerevisiae) Down
20343 Sell Selectin, lymphocyte Down
21781 Tfdp1 Transcription factor Dp 1 Down
Fedeli et al. www.pnas.org/cgi/content/short/1612024114 6 of 7
Table S1. Cont.
Gene ID Gene symbol Gene Regulation
21844 Tiam1 T-cell lymphoma invasion and metastasis 1 Down
65963 Tmem176b Transmembrane protein 176B Down
21973 Top2a Topoisomerase (DNA) II α Down
Genes modulated upon thymic iNKT cell development and maturation in both the present study and in the Immgen study (21). We
compared the genes modulated in the present study in iNKTWT 3 with respect to iNKTWT 1–2 [with adjusted P < 0.05 and fold-change >
2, as performed by Cohen et al. (21)] with the genes that were up- or down-regulated in the Immgen study in the maturation between
stages 2 and 3.The P values of the overlap between the two datasets were statistically significant: P = 5.3e-19, adjusted P = 4.3e-17 for
the 34 down-regulated genes; P = 2.3e-37, adjusted P = 1.9e-35 for the 31 up-regulated genes.
Dataset S1. Limma analysis of differentially expressed genes
Dataset S1
Differentially expressed genes among the five cellular types considered were identified through Limma analysis with a 5% FDR threshold.
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